MAGE-A1-derived peptide acetate, a high-purity, class I MHC-restricted tumor antigen, potently activates cytotoxic T-lymphocytes against MAGE-A1-expressing tumors. Essential for cancer vaccine development, immune monitoring, and driving T-cell expansion for adoptive cell therapy research.
Usually ships within 24 hours.